Methylprednisolone use in hospitalised COVID-19 patients: a retrospective study

References

• Corral-Gudino, L., Bahamonde, A., Arnaiz-Revillas, F., Gómez-Barquero, J., Abadía-Otero, J., García-Ibarbia, C., Mora, V., Cerezo-Hernández, A., Hernández, J. L., López-Muñíz, G., Hernández-Blanco, F., Cifrián, J. M., Olmos, J. M., Carrascosa, M., Nieto, L., Fariñas, M. C., & Riancho, J. A. (2021). Methylprednisolone in adults hospitalized with COVID-19 pneumonia : An open-label randomized trial (GLUCOCOVID). Wiener Klinische Wochenschrift, 133(7–8), 303–311. https://doi.org/10.1007/s00508-020-01805-8
   PubMed Web of Science ®Google Scholar
• Edalatifard, M., Akhtari, M., Salehi, M., Naderi, Z., Jamshidi, A., Mostafaei, S., … Rostamian, A. (2020). Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: Results from a randomised controlled clinical trial. European Respiratory Journal, 56(6), 1–13. https://doi.org/10.1183/13993003.02808-2020.
   Web of Science ®Google Scholar
• Go, R. C., Shah, R., Nyirenda, T., Oe, Y., Sarfraz, K., Panthappattu, J. J., Philip, L., Bheeman, C., Shah, N., Shah, S., Dar, S., Hung, S., Rahman, W., Im, H., Marafelias, M., Omidvari, K., Pradhan, A., Sadikot, S., Rose, K. M., … Josephs, J. (2021). Methylprednisolone and 60 days in hospital survival in coronavirus disease 2019 pneumonia. Critical Care Explorations, 3, e0493. https://doi.org/10.1097/cce.0000000000000493
   PubMedGoogle Scholar
• Hasan, S. S., Kow, C. S., Mustafa, Z. U., & Merchant, H. A. (2021). Does methylprednisolone reduce the mortality risk in hospitalized COVID-19 patients? A meta-analysis of randomized control trials. Expert Review of Respiratory Medicine, 15(8), 1049–1055. https://doi.org/10.1080/17476348.2021.1925546
   PubMed Web of Science ®Google Scholar
• Horby, P., Lim, W. S., Emberson, J. R., Mafham, M., Bell, J. L., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., Prudon, B., Green, C., Felton, T., Chadwick, D., Rege, K., Fegan, C., Chappell, L. C., Faust, S. N., Jaki, T., … Landray, M. J. (2021). Dexamethasone in hospitalized patients with Covid-19. New England Journal of Medicine, 384(8), 693–704. https://doi.org/10.1056/NEJMoa2021436
   PubMed Web of Science ®Google Scholar
• Jeronimo, C. M. P., Farias, M. E. L., Val, F. F. A., Sampaio, V. S., Alexandre, M. A. A., Melo, G. C., Safe, I. P., Borba, M. G. S., Netto, R. L. A., Maciel, A. B. S., Neto, J. R. S., Oliveira, L. B., Figueiredo, E. F. G., Oliveira Dinelly, K. M., de Almeida Rodrigues, M. G., Brito, M., Mourão, M. P. G., Pivoto João, G. A., Hajjar, L. A., … Lacerda, M. V. G. (2021). Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019 (COVID-19; Metcovid): A randomized, double-blind, phase IIb, placebo-controlled trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 72(9), e373–e381. https://doi.org/10.1093/cid/ciaa1177
   PubMed Web of Science ®Google Scholar
• Jiang, X., Zhang, C., Pan, Y., Cheng, X., & Zhang, W. (2023). Effects of C-reactive protein trajectories of critically ill patients with sepsis on in-hospital mortality rate. Scientific Reports, 13(1), 15223. https://doi.org/10.1038/s41598-023-42352-2
   PubMed Web of Science ®Google Scholar
• Kori, N., Islahudin, F., Abd Rahim, M. Y., Periyasamy, P., Shah, N. M., Hatah, E. M., & Lan, L. C. (2022). Corticosteroid effectiveness among hospitalised COVID-19 patients in Malaysia. The Journal of Infection in Developing Countries, 16(09), 1390–1397. https://doi.org/10.3855/jidc.16039
   Google Scholar
• Lu, G., & Wang, J. (2020). Dynamic changes in routine blood parameters of a severe COVID-19 case. January.
   Google Scholar
• Ministry of Health Malaysia. (2023). COVID-19 management guidelines in Malaysia No.5 / 2020. Annex 2e: clinical management of confirmed COVID-19 case in adult and paediatric - updated 28/12/2023. Retrieved March 2, 2024.
   Google Scholar
• National Institute of Health. (2024). COVID-19 treatment guidelines panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. Available at https://www.covid19treatmentguidelines.nih.gov/
   Google Scholar
• Nersesjan, V., Amiri, M., Christensen, H. K., Benros, M. E., & Kondziella, D. (2020). Thirty-day mortality and morbidity in COVID-19 positive vs. COVID-19 negative individuals and vs. individuals tested for influenza A/B: a population-based study. Frontiers in Medicine, 7, 598272. https://doi.org/10.3389/fmed.2020.598272
   Web of Science ®Google Scholar
• Papamanoli, A., Yoo, J., Grewal, P., Predun, W., Hotelling, J., Jacob, R., Mojahedi, A., Skopicki, H. A., Mansour, M., Marcos, L. A., & Kalogeropoulos, A. P. (2021). High-dose methylprednisolone in nonintubated patients with severe COVID-19 pneumonia. European Journal of Clinical Investigation, 51(2), 1–10. https://doi.org/10.1111/eci.13458
   Web of Science ®Google Scholar
• Pharmaceutical Services Division Ministry of Health Malaysia. (2010). Guidelines for Inpatient Pharmacy Practice.
   Google Scholar
• Pinzón, M. A., Ortiz, S., Holguín, H., Betancur, J. F., Arango, D. C., Laniado, H., Arias, C. A., Munõz, B., Quiceno, J., Jaramillo, D., & Ramirez, Z. (2021). Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia. PLoS One, 16(5 May), 1–13. https://doi.org/10.1371/journal.pone.0252057
   Web of Science ®Google Scholar
• Tang, X., Feng, Y. M., Ni, J. X., Zhang, J. Y., Liu, L. M., Hu, K., Wu, X. Z., Zhang, J. X., Chen, J. W., Zhang, J. C., Su, J., Li, Y. L., Zhao, Y., Xie, J., Ding, Z., He, X. L., Wang, W., Jin, R. H., Shi, H. Z., & Sun, B. (2021). Early use of corticosteroid may prolong SARS-CoV-2 shedding in non-intensive care unit patients with COVID-19 pneumonia: A multicenter, single-blind, randomized control trial. Respiration; International Review of Thoracic Diseases, 100(2), 116–126. https://doi.org/10.1159/000512063
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2020). Corticosteroids for COVID-19. Living guidance 2 September 2020. World Health Organization. Available at https://iris.who.int/rest/bitstreams/1299344/retrieve.
   Google Scholar
• Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., Zhang, Y., Song, J., Wang, S., Chao, Y., Yang, Z., Xu, J., Zhou, X., Chen, D., Xiong, W., … Song, Y. (2020). Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Internal Medicine, 180(7), 934–943. https://doi.org/10.1001/jamainternmed.2020.0994
   PubMed Web of Science ®Google Scholar